Hormonal status modulates circulating endothelial progenitor cells
- First Online:
- Cite this article as:
- Bulut*, D., Albrecht*, N., Imöhl, M. et al. Clin Res Cardiol (2007) 96: 258. doi:10.1007/s00392-007-0494-z
Endothelial progenitor cells (EPCs) may have an important role in vascular homeostasis and repair.
We examined the level of circulating EPCs in pre- (n = 22; mean age 28.7 years), and postmenopausal healthy females without (n = 30; mean age 61.6 years) or under current hormone replacement therapy (HRT) (n = 19; mean age 59.8 years).
Premenopausal females had the highest level of circulating EPCs (0.147 ± 0.076‰ of polymorphnuclear cells). The level of EPCs was lowest in postmenopausal females (0.094 ± 0.058‰), and increased significantly with HRT on average by 25.5%. In addition, the proliferative capacity of circulating EPCs was assessed under cell culture conditions. This capacity was significantly increased in EPCs isolated from postmenopausal subjects under current HRT as compared to corresponding samples obtained from postmenopausal females without HRT.
This observation is in line with the hypothesis that the hormonal status in females modulates the cardiovascular risk and that circulating EPCs could be involved in this phenomenon.